Company Name:Sage Therapeutics Inc.
CEO: Jeffrey M. Jonas

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Sage Therapeutics Inc is a biopharmaceutical company conducting development programs and clinical trials to discover medicines for central nervous system disorders. It has development programs for refractory status epilepticus, and Parkinson's di-sease.


Key numbers

Market Capitalization:3958895200
Shares Outstanding: 51818000
Float: 50885121
Next Earning Date:2020-02-24
TTm EPS: -13.511
TTm Dividend Rate:
200 days moving average:148.76
50 days moving average: 102.32
One day percent Change: 3.12



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,